Free US stock insider buying and selling tracking with regulatory filing analysis for inside information on company health and management confidence. We monitor corporate insider transactions because company officers often have the best understanding of their business prospects and future outlook. We provide 13D filings, insider buying and selling data, and trend analysis for comprehensive coverage. Get inside information with our comprehensive insider tracking and analysis tools for informed investment decisions.
NovaBay Pharmaceuticals Inc. (NBY) is a specialty pharmaceutical company trading at a current price of $1.95 as of 2026-04-13, marking a 22.64% gain in recent trading activity. This analysis covers key technical levels to monitor for NBY, prevailing market context for the small-cap biotech sector, and potential near-term price scenarios based on current market data. No recent earnings data is available for the company as of the current date, so this analysis focuses primarily on technical and se
What accelerates growth of NovaBay Pharmaceuticals (NBY) Stock | Price at $1.95, Up 22.64% - Crowd Consensus Signals
NBY - Stock Analysis
3686 Comments
1346 Likes
1
Lowene
Registered User
2 hours ago
Anyone else here for answers?
👍 283
Reply
2
Patrizia
Insight Reader
5 hours ago
I don’t know why but I feel late again.
👍 27
Reply
3
Tiarra
Returning User
1 day ago
Offers clarity on what’s driving current market movements.
👍 208
Reply
4
Quintell
Active Contributor
1 day ago
Very readable and professional analysis.
👍 42
Reply
5
Beyan
Experienced Member
2 days ago
Easy to follow and offers practical takeaways.
👍 241
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.